Download
s12885-021-08140-9.pdf 1,47MB
WeightNameValue
1000 Titel
  • Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples
1000 Autor/in
  1. Kriegsmann, Katharina |
  2. Zgorzelski, Christiane |
  3. Muley, Thomas |
  4. Christopoulos, Petros |
  5. Thomas, Michael |
  6. Winter, Hauke |
  7. Eichhorn, Martin |
  8. Eichhorn, Florian |
  9. von Winterfeld, Moritz |
  10. Herpel, Esther |
  11. Goeppert, Benjamin |
  12. Stenzinger, Albrecht |
  13. Herth, Felix J. F. |
  14. Warth, Arne |
  15. Kriegsmann, Mark |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-01
1000 Erschienen in
1000 Quellenangabe
  • 21(1):486
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12885-021-08140-9 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088012/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Synaptophysin, chromogranin and CD56 are recommended markers to identify pulmonary tumors with neuroendocrine differentiation. Whether the expression of these markers in pulmonary adenocarcinoma and pulmonary squamous cell carcinoma is a prognostic factor has been a matter of debate. Therefore, we investigated retrospectively a large cohort to expand the data on the role of synaptophysin, chromogranin and CD56 in non-small cell lung cancer lacking morphological features of neuroendocrine differentiation.!##!Methods!#!A cohort of 627 pulmonary adenocarcinomas (ADC) and 543 squamous cell carcinomas (SqCC) lacking morphological features of neuroendocrine differentiation was assembled and a tissue microarray was constructed. All cases were stained with synaptophysin, chromogranin and CD56. Positivity was defined as > 1% positive tumor cells. Data was correlated with clinico-pathological features including overall and disease free survival.!##!Results!#!110 (18%) ADC and 80 (15%) SqCC were positive for either synaptophysin, chromogranin, CD56 or a combination. The most commonly positive single marker was synaptophysin. The least common positive marker was chromogranin. A combination of ≤2 neuroendocrine markers was positive in 2-3% of ADC and 0-1% of SqCC. There was no significant difference in overall survival in tumors with positivity for neuroendocrine markers neither in ADC (univariate: P = 0.4; hazard ratio [HR] = 0.867; multivariate: P = 0.5; HR = 0.876) nor in SqCC (univariate: P = 0.1; HR = 0.694; multivariate: P = 0.1, HR = 0.697). Likewise, there was no significant difference in disease free survival.!##!Conclusions!#!We report on a cohort of 1170 cases that synaptophysin, chromogranin and CD56 are commonly expressed in ADC and SqCC and that their expression has no impact on survival, supporting the current best practice guidelines.
1000 Sacherschließung
lokal Carcinoma, Squamous Cell/mortality [MeSH]
lokal Carcinoma, Squamous Cell/chemistry [MeSH]
lokal Biomarkers
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal CD56
lokal Lung Neoplasms/chemistry [MeSH]
lokal Tissue Array Analysis [MeSH]
lokal Cell Differentiation [MeSH]
lokal Male [MeSH]
lokal Adenocarcinoma/pathology [MeSH]
lokal Carcinoma, Squamous Cell/pathology [MeSH]
lokal Biomarkers, Tumor/analysis [MeSH]
lokal Research Article
lokal Synaptophysin/analysis [MeSH]
lokal Female [MeSH]
lokal Lung Neoplasms/mortality [MeSH]
lokal Immunohistochemistry
lokal Chromogranin
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Adenocarcinoma/chemistry [MeSH]
lokal Retrospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal CD56 Antigen/analysis [MeSH]
lokal Non-small cell lung cancer
lokal Disease-Free Survival [MeSH]
lokal Synaptophysin
lokal Lung Neoplasms/pathology [MeSH]
lokal Analysis of Variance [MeSH]
lokal Adenocarcinoma/mortality [MeSH]
lokal Chromogranins/analysis [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S3JpZWdzbWFubiwgS2F0aGFyaW5h|https://frl.publisso.de/adhoc/uri/WmdvcnplbHNraSwgQ2hyaXN0aWFuZQ==|https://frl.publisso.de/adhoc/uri/TXVsZXksIFRob21hcw==|https://frl.publisso.de/adhoc/uri/Q2hyaXN0b3BvdWxvcywgUGV0cm9z|https://frl.publisso.de/adhoc/uri/VGhvbWFzLCBNaWNoYWVs|https://frl.publisso.de/adhoc/uri/V2ludGVyLCBIYXVrZQ==|https://frl.publisso.de/adhoc/uri/RWljaGhvcm4sIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/RWljaGhvcm4sIEZsb3JpYW4=|https://frl.publisso.de/adhoc/uri/dm9uIFdpbnRlcmZlbGQsIE1vcml0eg==|https://frl.publisso.de/adhoc/uri/SGVycGVsLCBFc3RoZXI=|https://frl.publisso.de/adhoc/uri/R29lcHBlcnQsIEJlbmphbWlu|https://frl.publisso.de/adhoc/uri/U3RlbnppbmdlciwgQWxicmVjaHQ=|https://frl.publisso.de/adhoc/uri/SGVydGgsIEZlbGl4IEouIEYu|https://frl.publisso.de/adhoc/uri/V2FydGgsIEFybmU=|https://orcid.org/0000-0002-7319-3646
1000 Hinweis
  • DeepGreen-ID: 41494feacd124832a5e83296a0bfdddc ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6462805.rdf
1000 Erstellt am 2023-11-15T14:39:36.329+0100
1000 Erstellt von 322
1000 beschreibt frl:6462805
1000 Zuletzt bearbeitet Thu Nov 30 20:29:04 CET 2023
1000 Objekt bearb. Thu Nov 30 20:29:04 CET 2023
1000 Vgl. frl:6462805
1000 Oai Id
  1. oai:frl.publisso.de:frl:6462805 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source